03-20201. Agency Information Collection Activities; Submission for OMB Review; Comment Request; Requirements for Medicated Feed Mill License  

  • Start Preamble

    AGENCY:

    FoodStart Printed Page 47332 and Drug Administration, HHS.

    ACTION:

    Notice.

    SUMMARY:

    The Food and Drug Administration (FDA) is announcing that the proposed collection of information listed below has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.

    DATES:

    Submit written comments on the collection of information by September 8, 2003.

    ADDRESSES:

    OMB is still experiencing significant delays in the regular mail, including first class and express mail, and messenger deliveries are not being accepted. To ensure that comments on the information collection are received, OMB recommends that written comments be faxed to the Office of Information and Regulatory Affairs, OMB, Attn: Fumie Yokota, Desk Officer for FDA, FAX: 202-395-6974.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Denver Presley, Office of Management Programs (HFA-250), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1472.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance.

    Medicated Feed Mill License Application—21 CFR Part 515 (OMB Control Number 0910-0037)—Extension

    In the Federal Register of November 19, 1999 (64 FR 63195), FDA published a final rule implementing the feed mill licensing provisions of the Animal Drug Availability Act of 1966 (Public Law 104-250). The rule added a new 21 CFR part 515 to provide the requirements for medicated feed mill licensing.

    The rule sets forth the information to be included in medicated feed mill license applications and supplemental applications. It also sets forth the criteria for, among other things, the approval and refusal to approve a medicated feed mill license application, as well as the criteria for the revocation and/or suspension of a license.

    Respondents to this collection of information are individuals or firms that manufacture medicated animal feed.

    FDA estimates the burden of this collection of information as follows:

    Table 1.—Estimated Annual Reporting Burden1

    21 CFR SectionNo. of RespondentsAnnual Frequency per ResponsesTotal Annual ResponsesHours per ResponseTotal Hours
    515.107170.251.75
    515.1110011000.2525.00
    515.23251250.256.25
    515.300.1510.1524.003.60
    Total Burden Hours36.6
    1 There are no capital costs or operating and maintenance costs associated with this collection of information.

    Table 2.—Estimated Annual Recordkeeping Burden1

    21 CFR SectionNo. of RecordkeepersAnnual Frequency per RecordkeepingTotal Annual RecordsHours per RecordkeeperTotal Hours
    510.3051,16011,1600.0334.80
    1 There are no capital costs or operating and maintenance costs associated with this collection of information.

    The estimated number of respondents is derived from agency data on the number of medicated feed manufacturers entering the market each year, changing ownership or address, requesting voluntary revocation of a medicated feed mill license, and those involved in revocation and/or suspension of a license. The estimate of the time required for this reporting requirement is based on the agency communication with industry.

    Start Signature

    Dated: August 4, 2003.

    Jeffrey Shuren,

    Assistant Commissioner for Policy.

    End Signature End Supplemental Information

    [FR Doc. 03-20201 Filed 8-7-03; 8:45 am]

    BILLING CODE 4160-01-S

Document Information

Published:
08/08/2003
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
03-20201
Dates:
Submit written comments on the collection of information by September 8, 2003.
Pages:
47331-47332 (2 pages)
Docket Numbers:
Docket No. 2003N-0198
PDF File:
03-20201.pdf